<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04608136</url>
  </required_header>
  <id_info>
    <org_study_id>MU-CIRB 2019/255.0310</org_study_id>
    <nct_id>NCT04608136</nct_id>
  </id_info>
  <brief_title>Egg Yolk and Underlying Metabolisms on Modifying HDL Levels in Individuals With Metabolic Syndrome</brief_title>
  <official_title>Egg Yolk and Underlying Metabolisms on Modifying HDL Levels and Associated Genetics in Individuals With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Council of Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research compare the effects of low carbohydrate intake and consumption of 3 eggs per&#xD;
      day, and low energy diet on diabetes control and biomarkers of CVD in obese people.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research study examines the effects of changes in weight, metabolism of glucose and&#xD;
      cholesterol in the blood through diet and behavior modification. The main objective of this&#xD;
      study was to compare the effects of low carbohydrate intake and consumption of 3 eggs per&#xD;
      day, and low energy diet on diabetes control and biomarkers of CVD in obese people. In&#xD;
      addition, HDL quantity and size as well as HDL function was compared between the group who&#xD;
      ate the whole egg and the group who did not eat the yolk.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in weight following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>weight (kg) analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in body mass index following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>body mass index (kg/m^2) analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in waist circumference following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>waist circumference (cm) analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in lipid profiles concentration following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>Triglycerides (mg/dl), Cholesterol (mg/dl), HDL-cholesterol (mg/dl) and LDL-cholesterol (mg/dl) concentration analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in blood glucose and insulin concentration following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>HbA1C (%), glucose (mg/dl) and insulin (mg/dl) concentration analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in betahydroxybutirate concentration following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>betahydroxybutirate (mmol/L) concentration analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in electrolytes concentration following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>Na+ (mg/dl), K+ (mg/dl), Cl- (mg/dl) and HCO3- (mg/dl) concentration analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in physical activity</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>physical activity (MET-minutes/week) collect data by using questionnaires</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline Glycemia at 180 minutes</measure>
    <time_frame>Minutes after intake of 75 g glucose: 0, 30, 60, 90, 120, 180</time_frame>
    <description>glucose (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline Insulin at 180 minutes</measure>
    <time_frame>Minutes after intake of 75 g glucose: 0, 30, 60, 90, 120, 180</time_frame>
    <description>insulin (μU/ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>systolic and diastolic blood pressure (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in fasting leptin levels</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>leptin (mg/dl) concentration analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in energy intake following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>energy (kcal)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in carbohydrate following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>carbohydrate (g)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in protein intake following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>protein (g)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in fat intake following dietary intervention</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <description>fat (g)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Yolk ketogenic diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consume carbohydrate &lt; 10% and 3 whole eggs supplement per day in 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>White ketogenic diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consume carbohydrate &lt; 10% and 6 white eggs supplement per day in 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>decrease consumption of diet from typical (decreased energy 20%) but consume carbohydrate in normal level</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet intervention</intervention_name>
    <description>Volunteers will be instructed on dietary recommendation throughout the research program to achieve a stable daily energy intake.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>White ketogenic diet</arm_group_label>
    <arm_group_label>Yolk ketogenic diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. weight stable &gt; 3 months (changing &lt; 5%)&#xD;
&#xD;
          2. three or more of the following five criteria are met 2.1 waist circumference ≥ 90 cm&#xD;
             (men) or ≥ 80 cm (women) 2.2 fasting blood sugar ≥ 100 mg/dl 2.3 fasting triglyceride&#xD;
             (TG) level ≥ 150 mg/dl 2.4 fasting high-density lipoprotein (HDL) cholesterol level ≤&#xD;
             40 mg/dl (men) or ≤ 50 mg/dl (women) 2.5 blood pressure over 130/85 mmHg&#xD;
&#xD;
          3. can consume food that provided in project&#xD;
&#xD;
          4. healthy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. consume drugs i.e. weight loss drugs, herbal pills, asthma drugs, steroid drugs,&#xD;
             thyroid drugs, insulin injections, SGLT1 inhibitors drugs, SGLT2 inhibitors drugs,&#xD;
             sulfonylurea drugs, blood lipid-lowering drugs&#xD;
&#xD;
          2. people who exercise vigorously (&gt; 150 minutes per week)&#xD;
&#xD;
          3. people who are or have weight loss by consuming less than 30% of carbohydrates, or are&#xD;
             losing weight by other methods or who have eaten a specific diet as prescribed by a&#xD;
             doctor within the past 6 months&#xD;
&#xD;
          4. people who drink alcohol more than once a week&#xD;
&#xD;
          5. people who had a LDL level within 6 months &gt; 190 mg/dl&#xD;
&#xD;
          6. fasting blood glucose levels &gt; 250 mg/dl and using diabetes drugs other than metformin&#xD;
&#xD;
          7. people with heart disease, type 1 diabetes, renal impairment &gt; level 3A&#xD;
&#xD;
          8. history of cancer, lung disease, gastrointestinal disease&#xD;
&#xD;
          9. people who smoke, people with eating disorder, people who have received psychiatric&#xD;
             drugs&#xD;
&#xD;
         10. become a volunteer in a research project that is conducting a study related to food&#xD;
             consumption&#xD;
&#xD;
         11. people who are unable to keep up with the treatment or are expected to be absent in&#xD;
             this area for the next 4 months&#xD;
&#xD;
         12. pregnancy or breastfeeding&#xD;
&#xD;
         13. egg allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korapat Mayurasakorn, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Doctor in Family Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Korapat Mayurasakorn, MD.</last_name>
    <phone>+66 94 189 3266</phone>
    <email>korapat.may@mahidol.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Korapat Mayurasakorn, MD.</last_name>
      <phone>+66 94 189 3266</phone>
      <email>korapat.may@mahidol.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 21, 2020</study_first_submitted>
  <study_first_submitted_qc>October 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metabolic syndrome</keyword>
  <keyword>diabetes</keyword>
  <keyword>diet</keyword>
  <keyword>eggs</keyword>
  <keyword>cholesterol</keyword>
  <keyword>weight loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

